Glenmark Life Sciences' Share Price Reaches All-Time High, Outperforms Sector and Sensex
Glenmark Life Sciences, a midcap pharmaceutical company, has seen a surge in its share price, reaching an all-time high of Rs.1328.05 on September 14, 2024. Despite a slight dip, the stock is still trading higher than its moving averages, showcasing a positive trend. The company's impressive growth of 109.36% in the past year has caught the attention of investors and analysts.
Glenmark Life Sciences, a midcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high of Rs.1328.05 on September 14, 2024. This surge in price has caught the attention of investors and analysts alike.
According to MarketsMOJO, a leading stock market analysis platform, the current recommendation for Glenmark Life Sciences is 'Hold'. This is based on the company's recent performance and market trends.
In terms of price performance, Glenmark Life Sciences has outperformed the sector by 1.04% today. However, the stock has seen a slight dip after seven consecutive days of gains, with an intraday low of Rs.1276.55, a decrease of 2.13%.
Despite this, Glenmark Life Sciences is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
In the past year, Glenmark Life Sciences has shown an impressive growth of 109.36%, outperforming the Sensex's performance of 22.86%. This showcases the company's strong position in the pharmaceutical industry.
As a midcap company, Glenmark Life Sciences has been able to attract attention from investors due to its consistent growth and potential for future success. With its recent all-time high, the company is proving to be a strong player in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
